Nature Digital Medicine
Researchers found that 64 percent of mental health apps claimed efficacy, although only 14 percent included any evidence.
Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public.
Instant Blood Pressure, an app from Aura Labs, has been removed from the app store for more than two years.
Wearable activity monitors could be useful in assessing the health of cancer patients and making predictions about mortality and adverse events, according to a study published last week in Nature's Digital Medicine partner journal.
A new overview of systematic reviews of published randomized control trials of mobile health apps found just 23 RCTs of currently-available apps have been conducted, and less than half of those showed a positive health effect from the app in question.
Remote patient monitoring is one of the hot topics in digital health and has grown increasingly popular in the last decade.